Potential Zantac Plaintiffs Must Provide A Record Of Using The Medine

There are many ways to provide proof that you have used Zantac in the past

Thursday, November 19, 2020 - Zantac was the world's most popular heartburn and acid reflux medicine before being taken off of store shelves earlier this year. As recently as 2018, approximately 15 million Americans relied on it for relief of their acid indigestion symptoms. Last year the US Food and Drug Administration recalled the medicine citing the risk that Zantac and other forms of ranitidine tablets may have developed excessive levels of NDMA, a known carcinogen. Thousands of individuals with cancer now blame the drug for allegedly causing their stomach, bladder, colon, or other forms of cancer. Legal experts estimate that tens of thousands of cases may come forward in 2021 and beyond, claiming that Sanofi failed to warn them of Zantac cancer risks.

Zantac users may be wondering if they qualify to file a lawsuit against the manufacturer of the drug. Many who have already filed allege that Sanofi, the maker of Zantac, failed to meet their responsibilities to tell consumers what they knew or were obligated to know about the potential health hazards of taking the drug. Individuals that intend to file a claim should first consult a Zantac Cancer Lawyer and be prepared to produce documentation to support their allegations.

A Zantac Cancer lawyer may require that you produce your pharmacy's records of your Zantac or other forms of ranitidine's purchases to prove that you used the drug. Other ways to show Zantac usage include financial receipts or personal journal notations. It can also be helpful if your insurance claims or doctor visit records indicate a history of having acid reflux, gastrointestinal disease, or acid reflux.

After one proves using Zantac regularly and for more than a year or two, one must secure the medical records of having been diagnosed with cancer. Zantac cancer victims usually hire a Zantac cancer lawyer to do the necessary legwork to secure pharmacy records, doctor's office visits, and hospital records to lay a foundation for making their case. It is important to be able to prove the frequency with which one has taken Zantac since the more one takes it, the greater the alleged chances of developing the disease. Finally, the date that one began taking Zantac is critical, as is the date of the cancer diagnosis, according to the National Law Review.

Zantac cancer litigation is not a class-action lawsuit but rather individual lawsuits that are being grouped into multidistrict litigation to avoid repetition in administrative proceedings and streamline the discovery process. In 2021 a judge will select several Zantac Cancer plaintiffs to serve as bellwether trials that will guide proceedings in the future or lay a foundation for Sanofi to settle the remaining cases out of court. Large multidistrict litigation is underway against Johnson & Johnson and Bayer/Monsanto. If you or a loved one have developed cancer after frequently using Zantac, Zantac cancer attorneys offer a no-obligation free consultation before filing a claim.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.